HomeDiversity & InclusionVirtua's Pullin: Taking my shot at building trust

Virtua’s Pullin: Taking my shot at building trust

While health systems and their frontline teams have been braving the devastation of COVID-19 with caring hearts and dedicated skill, researchers around the globe have been working tirelessly to develop vaccines to combat the deadly virus that has stolen more than 1.5 million lives since the spring of this year.

In the midst of the darkest days, it was difficult to imagine how it would feel the moment safe vaccines were more than just a distant possibility.

And, when the glimmering vials of hope arrived at my health system one cold morning, I found myself overjoyed and conflicted all at the same time.

As a CEO of a major health system, I have always felt a deep responsibility for the health and well-being of our team and our community. Navigating the pandemic without a proven playbook, with more questions than answers, and with days of despair when our best efforts didn’t yield the intended outcomes for those we were caring for, has been humbling. From scouring the globe for available personal protective equipment to keep the frontline team members safe, to making heart-wrenching decisions to restrict families from their loved ones during their most vulnerable moments, there have been many challenges and emotional moments.

Yes, a safe vaccine in hand with a second one on its heels is beyond a moment worthy of celebration.

So, why the conflict?

Well, it came from a statement posed by a colleague I encountered in a meeting the very day the vaccine arrived.

Her concern centered on safety and trust. Safety, I explained, has been a key concern among health officials and experts. I confidently shared with her that no major safety concerns were uncovered in the FDA’s review of Pfizer’s vaccine. I also shared that some participants did experience temporary side effects that are in line with those people experience from other vaccines, including the flu shot. I told her what has been told to me — that any reactions signal that the vaccine is teaching the immune system how to handle something before you actually encounter it — which, hopefully you never will.

Then, I realized that it wasn’t the safety of the vaccine that she didn’t trust. As a person of color, she just didn’t trust.

Skepticism surrounding the vaccine is widespread in communities of color that have suffered disproportionately from the coronavirus. This country’s history of unethical experimentation on people of color has created understandable concern.

This colleague went on to tell me that she needed to see “people who looked like her” receiving the vaccine. Better yet, people of color and of influence who would be in the know receiving this vaccine would temper her hesitation.

As a black CEO, I realize I am that person she describes — that person of color and of influence who is “in the know.” I am compelled to join my clinical colleagues, including nurses, physicians and frontline caregivers of color, and lead by example. But, I don’t get to jump the line. I know the facts and I will be getting the vaccine as quickly as possible — after all of the prioritized, higher-risk, patient-facing heroes have received theirs. It’s an easy decision for me and one I want people to understand.

I realize the remarks of this one colleague represented so much more than her individual fears. She was sharing the apprehension of many. She was asking me, without asking me, to remember that. She reminded me that I, and others like me, carry an extra responsibility to be purposeful in our actions and bring others along whenever we can.

After nine months leading 15,000 courageous, resilient colleagues, there is nothing I wouldn’t do to show them leadership, confidence and support. I understand all too well the alternative to this vaccine, and it’s grim. As the coronavirus continues to threaten all people, and those of color most, dispelling skepticism is critical, and my role is key. I am not a caregiver or a frontline hero, but I represent them — and I will not let them down.

I will not be first, but I will be early, and I will talk boldly about the safety, effectiveness and importance of vaccinations to everyone, especially specific populations who need to see “people like me.” I will use my role to be a force for equality in medicine, and as we eliminate health disparities, we will slowly and steadily build trust through the consistency of our actions.

Dennis Pullin is CEO and president of Virtua Health.

Related Articles

Finding the Right Pediatrician for Your Baby and Your Family

Choosing a pediatrician is one of the earliest and most important decisions you make as a parent. Many parents research online, read reviews, and...

Heights University Hospital readies for suspension of emergency services

Heights University Hospital, in anticipation of suspending emergency department services on Saturday, March 14, at 7:30 p.m., will continue to provide various community health...

Rowan University’s Shreiber School to offer Master of Science in One Health

Beginning in fall 2026, Rowan University’s Shreiber School of Veterinary Medicine will offer a Master of Science in One Health (MSOH) to meet growing...

Bergen New Bridge Medical Center launches physician-led medical group

Bergen New Bridge Medical Center said March 12 that it launched One Bergen Health, PC, a physician-led medical group designed to deliver high-quality, community-based...

Health Monitor Network appoints Bellonia to EVP, chief human resources officer

Health Monitor Network, the trusted leader and innovator in point of care (POC) marketing based in Montvale, announced the appointment of Louise DeBellonia as...

Basking Ridge-based fertility company forges partnership with Costco, health care platform Sesame 

Basking Ridge-based fertility leader IVI RMA North America announced it signed a strategic partnership with Costco and Sesame to transform how fertility care is...

Latest Articles

Appwork of Ramsey announces another $7M investment to advance multifamily maintenance solutions 

AppWork, a property technology platform helping multifamily owners and operators eliminate maintenance backlogs and improve resident satisfaction, on March 16 announced the raise of...

Schuman Cheese sees fourth-generation leadership changes

Fairfield-based Schuman Cheese, a fourth-generation family-owned company and leading importer and distributor of specialty cheeses in North America, announced several changes in its leadership...

NAI DiLeo-Bram completes 20,000 SF in office leases in select Central Jersey market

NAI DiLeo-Bram & Co. recently completed four office leases totaling 20,000 square feet in the Middlesex County market. Helmed by Executive Vice President Robert Dinner, the deals span...

Grant supports 37 postdoctoral researchers at three Rutgers schools

Rutgers University has received a $1.5 million grant from the Gordon and Betty Moore Foundation to support 37 postdoctoral researchers across 12 scientific disciplines. The...

NJEDA board OKs $20M to support FIFA World Cup 2026

The New Jersey Economic Development Authority board recently approved a $20 million allocation to the FIFA World Cup 2026 New York New Jersey Host...

Campbell’s appoints Levine chief investor relations officer, succeeding Gardy

The Campbell’s Company in Camden announced the appointment of Joshua Levine as chief investor relations officer, effective March 18. Levine will report to Chief...

Latest Articles

Appwork of Ramsey announces another $7M investment to advance multifamily maintenance solutions 

AppWork, a property technology platform helping multifamily owners and operators eliminate maintenance backlogs and improve resident satisfaction, on March 16 announced the raise of...

Schuman Cheese sees fourth-generation leadership changes

Fairfield-based Schuman Cheese, a fourth-generation family-owned company and leading importer and distributor of specialty cheeses in North America, announced several changes in its leadership...

NAI DiLeo-Bram completes 20,000 SF in office leases in select Central Jersey market

NAI DiLeo-Bram & Co. recently completed four office leases totaling 20,000 square feet in the Middlesex County market. Helmed by Executive Vice President Robert Dinner, the deals span...

Grant supports 37 postdoctoral researchers at three Rutgers schools

Rutgers University has received a $1.5 million grant from the Gordon and Betty Moore Foundation to support 37 postdoctoral researchers across 12 scientific disciplines. The...

NJEDA board OKs $20M to support FIFA World Cup 2026

The New Jersey Economic Development Authority board recently approved a $20 million allocation to the FIFA World Cup 2026 New York New Jersey Host...